Gut Bacterium Roseburia inulinivorans and Age-Related Muscle Loss: A Narrative Review
This narrative review summarizes evidence on the gut-muscle axis, focusing on a reported association between the gut bacterium Roseburia inulinivorans and muscle strength in older adults, plus a mouse finding. The authors call for human randomized trials and longitudinal studies before clinical use. [1]
Automatic summary · not editorially reviewed
The key findings
The review says R. inulinivorans shows a species-specific association with muscle strength and is a candidate target for nutraceutical interventions against sarcopenia and cachexia. [1]
Older adults with detectable R. inulinivorans had 29% higher handgrip strength without a concomitant increase in cardiorespiratory capacity. [1]
In a mouse model, oral supplementation produced about a 30% increase in forelimb grip strength. [1]
The source at a glance
- Study type / format
- Narrative review based primarily on one 2026 study, supplemented by related literature.
- Population / context
- Older adults (human findings) and a murine model (mouse findings), as described in the abstract.
- Summary based on
- Study abstract
- Original publication
- October 11, 2026
Review focus: gut-muscle axis and R. inulinivorans
Age-related muscle loss, called sarcopenia, is described as a major health burden in a globally ageing population. The review says the gut-muscle axis — the relationship between the gut microbiome and skeletal muscle — is increasingly researched, but specific responsible microbial species and mechanisms remain poorly identified. Its aim is to summarize current evidence on this axis, with particular attention to the association between the intestinal bacterium Roseburia inulinivorans and muscle performance reported in a 2026 Gut publication, and to assess clinical and therapeutic relevance. The authors state that R. inulinivorans shows a species-specific association with muscle strength and call it a candidate target for nutraceutical interventions against sarcopenia and cachexia.
Supporting source [1]
Human correlations and mouse grip-strength result
The review is based primarily on the study by Martinez-Tellez et al. (2026), supplemented by literature on the gut-muscle axis, sarcopenia and the ageing microbiome. Reported findings: the relative abundance of R. inulinivorans positively correlated with handgrip strength, leg press and bench press performance. Older adults with detectable R. inulinivorans showed 29% higher handgrip strength, without a concomitant increase in cardiorespiratory capacity. In a murine model, oral supplementation produced approximately a 30% increase in forelimb grip strength. The mechanism may operate not via butyrate but through activation of the purine and pentose phosphate pathways in muscle tissue.
Supporting source [1]
Open questions before any clinical use
The review describes R. inulinivorans as a candidate target, not an established therapy. The authors state that human randomized clinical trials and longitudinal studies accounting for sex differences are required to confirm these findings. The human evidence described is correlational: a positive correlation between bacterial abundance and strength measures, and a comparison of older adults with versus without detectable R. inulinivorans. The mouse result comes from an animal model and does not by itself show a benefit for human muscle or lifespan.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. The human findings described are correlational, the grip-strength result comes from a mouse model, and the authors themselves state that human randomized trials and longitudinal studies accounting for sex differences are needed.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Gulyás-Oldal V, Patay G, Dézsi C, Bezzegh A, Szili K. · europepmc.org · October 11, 2026